POZ July-August 2019
POZ July-August 2019
In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Features
Rising Above
People living with HIV are also facing cancer as they age.
25 Years of HIV Research
The increasing mastery over the virus is one of humanity’s crowning achievements.
2019 HIV Drug Chart
This quick-reference chart compares available antiretroviral (ARV) medication options, including adult dosing and dietary restrictions.
Editor’s Letter
I Won’t Back Down
Living with cancer and HIV is the theme of this issue.
POZ Q+A
Viral Control
The Office of HIV and AIDS Malignancy at the National Cancer Institute coordinates cancer and HIV research.
POZ Planet
Around the World
A look at HIV-related headlines across the globe
MAC Milestones
In 25 years, the MAC AIDS Fund has raised $500 million. It celebrates with an expanded mission—and a new name!
POZ at 25—July-August
A look at July-August issues from the POZ archives
Everyday
Everyday—July-August 2019
Here are some important dates in AIDS history.
Voices
My Path
HIV advocate Murray Penner describes how the Undetectable Equals Untransmittable message affected his journey living with the virus.
My Challenge
Brian Gaither, an HIV-negative gay man and cofounder of the Pride Foundation of Maryland, confronts his past bigotry.
Spotlight
R.I.P. Andy Vélez
The longtime AIDS activist died of complications resulting from a severe fall on May 14 at the age of 80.
Care and Treatment
New Two-Drug Regimen
The Food and Drug Administration has approved a new treatment for people living with HIV.
Cardiac Dysfunction Details
A recent review of 54 studies indicates that people living with HIV are at high risk for experiencing cardiac dysfunction.
Copping to COPD
People with the chronic inflammatory lung disease are about two times more likely to have a heart attack.
Liver Cancer Prognosis
There is not a significant difference in three-year liver cancer survival rates between people living with HIV and people who are not.
Research Notes
Prevention: HIV Transmission
Which HIV-positive demographics pass on the virus?
Treatment: Trogarzo Durability
A clinical trial has confirmed that new HIV treatment Trogarzo suppresses one’s viral load.
Cure: Role of Macrophages
Any HIV cure on the horizon will have to tackle macrophage immune cells as well as CD4 T Cells, a study indicates.
Concerns: Opiod ODs
A study conducted by researchers at the CDC suggests that people with HIV are some of the hardest hit by the opioid crisis.
Heroes
Employment Needs
Mark Misrok addresses employment and HIV.
Digital Edition
POZ July/August 2019
Read the digital edition!
